| PET imaging of tau deposition in the aging human brain M Schöll*, SN Lockhart*, DR Schonhaut, JP O’Neil, M Janabi, ... Neuron 89 (5), 971-982, 2016 | 966 | 2016 |
| Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease R Ossenkoppele, DR Schonhaut, M Schöll, SN Lockhart, N Ayakta, ... Brain 139 (5), 1551-1567, 2016 | 896 | 2016 |
| Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ... The Lancet Neurology 19 (5), 422-433, 2020 | 602 | 2020 |
| Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity S Palmqvist*, M Schöll*, O Strandberg, N Mattsson, E Stomrud, ... Nature Communications 8 (1), 1214, 2017 | 597 | 2017 |
| Amyloid biomarkers in Alzheimer's disease K Blennow, N Mattsson, M Schöll, O Hansson, H Zetterberg Trends in pharmacological sciences 36 (5), 297-309, 2015 | 486 | 2015 |
| Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG SF Carter*, M Schöll*, O Almkvist, A Wall, H Engler, B Långström, ... Journal of Nuclear Medicine 53 (1), 37-46, 2012 | 413 | 2012 |
| Discriminative accuracy of [18F] flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders R Ossenkoppele, GD Rabinovici, R Smith, H Cho, M Schöll, O Strandberg, ... Jama 320 (11), 1151-1162, 2018 | 303 | 2018 |
| Brain charts for the human lifespan RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ... Nature 604 (7906), 525-533, 2022 | 277 | 2022 |
| Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease E Rodriguez-Vieitez, L Saint-Aubert, SF Carter, O Almkvist, K Farid, ... Brain 139 (3), 922-936, 2016 | 255 | 2016 |
| Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology NJ Ashton, TA Pascoal, TK Karikari, AL Benedet, J Lantero-Rodriguez, ... Acta neuropathologica 141, 709-724, 2021 | 237 | 2021 |
| A walk through tau therapeutic strategies S Jadhav, J Avila, M Schöll, GG Kovacs, E Kövari, R Skrabana, LD Evans, ... Acta neuropathologica communications 7 (1), 1-31, 2019 | 216 | 2019 |
| Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease A Prestia, A Caroli, WM Van Der Flier, R Ossenkoppele, B Van Berckel, ... Neurology 80 (11), 1048-1056, 2013 | 203 | 2013 |
| 18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease N Mattsson, M Schöll, O Strandberg, R Smith, S Palmqvist, PS Insel, ... EMBO molecular medicine 9 (9), 1212-1223, 2017 | 185 | 2017 |
| Microglial activation and tau propagate jointly across Braak stages TA Pascoal, AL Benedet, NJ Ashton, MS Kang, J Therriault, M Chamoun, ... Nature medicine 27 (9), 1592-1599, 2021 | 176 | 2021 |
| Biomarkers for tau pathology M Schöll, A Maass, N Mattsson, NJ Ashton, K Blennow, H Zetterberg, ... Molecular and Cellular Neuroscience 97, 18-33, 2019 | 174 | 2019 |
| Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative TK Karikari, AL Benedet, NJ Ashton, J Lantero Rodriguez, A Snellman, ... Molecular psychiatry 26 (2), 429-442, 2021 | 173 | 2021 |
| 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers R Smith, A Puschmann, M Schöll, T Ohlsson, J Van Swieten, M Honer, ... Brain 139 (9), 2372-2379, 2016 | 172 | 2016 |
| A multicentre validation study of the diagnostic value of plasma neurofilament light NJ Ashton, S Janelidze, A Al Khleifat, A Leuzy, EL van der Ende, ... Nature communications 12 (1), 3400, 2021 | 164 | 2021 |
| Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with … A Kadir, A Marutle, D Gonzalez, M Schöll, O Almkvist, M Mousavi, ... Brain 134 (1), 301-317, 2011 | 163 | 2011 |
| Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers M Schöll, A Wall, S Thordardottir, D Ferreira, N Bogdanovic, B Långström, ... Neurology 79 (3), 229-236, 2012 | 158 | 2012 |
Nicholas James AshtonUniversity of Gothenburg / King's College LondonVerified email at gu.se
